Skip to the beginning of the images gallery

Verubecestat (MK-8931) - ≥98%, high purity , Beta-secretase 1 inhibitor, CAS No.1286770-55-5, Beta-secretase 1 inhibitor

Specifications & Purity: ≥98%

CAS#: 1286770-55-5
Formula: C₁₇H₁₇F₂N₅O₃S
Molecular Weight: 409.41
PubChem CID: 51352361

Item Number

M276428

Grouped product items
SKU	Size	Availability	Price
M276428-1mg	1mg	Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!	$16.90
M276428-5mg	5mg	Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!	$68.90
M276428-25mg	25mg	In stock	$187.90
M276428-100mg	100mg	In stock	$444.90

Selective, potent Beta-sectetase inhibitor

View related series

beta-secretase 1 Inhibitor beta-secretase 2 Inhibitor

Basic Description

Synonyms	Verubecestat\|1286770-55-5\|MK-8931\|Verubecestat Free Base\|SCH-900931\|SCH900931\|SCH 900931\|Verubecestat (MK-8931)\|J1I0P6WT7T\|N-[3-[(5R)-3-amino-2,5-dimethyl-1,1-dioxo-6H-1,2,4-thiadiazin-5-yl]-4-fluorophenyl]-5-fluoropyridine-2-carboxamide\|C17H17F2N5O3S\|(R)
Specifications & Purity	≥98%
Storage Temp	Protected from light,Store at -20°C
Shipped In	Dry ice
Action Type	INHIBITOR
Mechanism of action	Beta-secretase 1 inhibitor

Associated Targets

BACE1 Tchem Beta-secretase 1 10 Activities

Discover Target: BACE1

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

BACE2 Tchem Beta-secretase 2 7 Activities

Discover Target: BACE2

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

Names and Identifiers

IUPAC Name	N-[3-[(5R)-3-amino-2,5-dimethyl-1,1-dioxo-6H-1,2,4-thiadiazin-5-yl]-4-fluorophenyl]-5-fluoropyridine-2-carboxamide
INCHI	InChI=1S/C17H17F2N5O3S/c1-17(9-28(26,27)24(2)16(20)23-17)12-7-11(4-5-13(12)19)22-15(25)14-6-3-10(18)8-21-14/h3-8H,9H2,1-2H3,(H2,20,23)(H,22,25)/t17-/m0/s1
InChi Key	YHYKUSGACIYRML-KRWDZBQOSA-N
Canonical SMILES	CC1(CS(=O)(=O)N(C(=N1)N)C)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)F)F
Isomeric SMILES	C[C@]1(CS(=O)(=O)N(C(=N1)N)C)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)F)F
PubChem CID	51352361
Molecular Weight	409.41

ChEMBL Ligand

PubChem CID

CAS Registry No.

RCSB PDB Ligand

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

4 results found

Lot Number	Certificate Type	Date	Item
F2229457	Certificate of Analysis	Apr 14, 2023	M276428
F2229458	Certificate of Analysis	Apr 14, 2023	M276428
F2229459	Certificate of Analysis	Apr 14, 2023	M276428
F2229460	Certificate of Analysis	Apr 14, 2023	M276428

References

1. Scott JD, Li SW, Brunskill AP, Chen X, Cox K, Cumming JN, Forman M, Gilbert EJ, Hodgson RA, Hyde LA et al.. (2016) Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease.. J Med Chem, 59 (23): (10435-10450). [PMID:27933948]
2. Egan MF, Kost J, Tariot PN, Aisen PS, Cummings JL, Vellas B, Sur C, Mukai Y, Voss T, Furtek C et al.. (2018) Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease.. N Engl J Med, 378 (18): (1691-1703). [PMID:29719179]
3. Egan MF, Kost J, Voss T, Mukai Y, Aisen PS, Cummings JL, Tariot PN, Vellas B, van Dyck CH, Boada M et al.. (2019) Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease.. N Engl J Med, 380 (15): (1408-1420). [PMID:30970186]

Solution Calculators

Molarity Calculator

Determine the necessary mass, volume, or concentration for preparing a solution.

Dilution Calculator

Determine the dilution needed to prepare a stock solution.